[EN] PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF<br/>[FR] INHIBITEURS PYRAZOLYL GUANIDINE DE LA F1F0-ATPASE ET LEURS UTILISATIONS THÉRAPEUTIQUES
申请人:LYCERA CORP
公开号:WO2012078874A1
公开(公告)日:2012-06-14
The invention provides pyrazolyl guanidine compounds that inhibit F1Fo-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
该发明提供了抑制F1Fo-ATPase的吡唑基胍化合物,并且提供了使用吡唑基胍化合物作为治疗药物治疗医学疾病的方法,例如免疫紊乱、炎症病状或癌症。